Evidencias Clínicas AQcognitive | Aora Life aoralife
+34 744 408 080
Logo Aora life

Evidencias Clínicas AQcognitive

Se trata de un complemento alimenticio evaluado y aprobado por Agencias Europeas (Bélgica, y España) según los estándares más exigentes.

REFERENCIAS BIBLIOGRÁFICAS

  1. DeFreudis: “Ginkgo biloba Extract (EGb 761): Pharmacological Activities and Clinical Applications, 1991.
  2. Sticher O.: “Biochemical, pharmaceutical and medicinal perspectives of Ginkgo preparations”, 1994.
  3. Van Beek T.A. et al.: “Determination of ginkgolides and bilobalide in Ginkgo biloba leaves and phytochemicals”, journal of chromatography, 1991.
  4. Hasler A. et al.: “Complex flavonol glycosides from the leaves of Ginkgo biloba”, Phytochemistry, 1992.
  5. “German Commission E monograph”, “Trockenextract (35-67:1) aus Ginkgo-biloba-Blättern Extract mit Aceton-Wasser”, Bundesanzeiger, 1994.
  6. Barth S.A. et al.: “Influences of Ginkgo biloba on cyclosporin induced lipid peroxidation in human livermicrosomes in comparison to vitamin E, glutathione and N-acethylcystine”, Biochemical pharmacology, 1991.
  7. Krieglstein J.: “Neuroprotectieve effects of Ginkgo biloba constituens”, European journal of pharmaceutical sciences, 1995.
  8. Braquet P.: “The ginkgolides: potent platelet-activating factor antagonist isolated from Ginkgo biloba”, Drugs of the future, 1987.
  9. Chatterjee S.S. et al.: “Pharmaceutical compositions containing bilobalide for the treatment of neuropathies”, 1986.
  10. Kleinen J., Knipschild P.: “Ginkgo biloba for cerebral insufficiency”, British journal of clinical pharmacology, 1992.
  11. Jung F. et al.: “Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers”, Arzneimittel-Forschung 1990.
  12. Bauer U.; “Six Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency”, Arzneimittelforschung 1984.
  13. Alonso, Jorge Rubén. El rol del Ginkgo biloba en la prevención de los trastornos de memoria, déficits cognitivos, arterioesclerosis y enfermedad de Al- zhéimer; {citado 25 febrero 2011}. Disponible en: www. soaljo.com.ar/tecnica/cerebral.php?sub=intro.
  14. Krieglstein J.: “Neuroprotectieve effects of Ginkgo biloba constituens”, European journal of pharmaceutical sciences, 1995.
  15. Kleinen J., Knipschild P.: “Ginkgo biloba for cerebral insufficiency”, British journal of clinical pharmacology, 1992.
  16. Jung F. et al.: “Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers”, Arzneimittel-Forschung 1990.
  17. Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29: 315-331.
  18. Busse E, Zimmer G, Schopohl B, et al. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittel-Forschung 1992;42:829-831.
  19. Kishi Y, Schmelzer JD, Yao JK, et al. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes 1999; 48: 2045-251.
  20. Liu J, Atamna H, Kuratsune H, Ames BN. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci 2002 Apr;959:133-66 2002; 959: 133-66.
  21. Lynch MA. Lipoic acid confers protection against oxidative injury in non-neuronal and neuronal tissue. Nutr Neurosci 2001;4(6):419-38 2002; 4: 419-38.
  22. Monograph:Alpha-Lipoic Acid. Altern Med Rev 1998; 3: 308-311.
  23. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997; 22: 359-378.
  24. Packer L, Witt E, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227-250.
  25. Passwater RA. Lipoic Acid: The Metabolic Antioxidant. New Canaan, CT: Keats Publishing, Inc; 1995:1-47.
  26. Scott BC, Aruoma OI, Evans PJ, et al. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic Res 1994; 20: 119-133.
  27. Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29: 315-331.
  28. Liu J, Atamna H, Kuratsune H, Ames BN. Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites. Ann N Y Acad Sci 2002 Apr;959:133-66 2002; 959: 133-66.
  29. Lynch MA. Lipoic acid confers protection against oxidative injury in non-neuronal and neuronal tissue. Nutr Neurosci 2001;4(6):419-38 2002; 4: 419-38.
  30. Monograph:Alpha-Lipoic Acid. Altern Med Rev 1998; 3: 308-311.
  31. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997; 22: 359-378.